Pantoprazol Ratiopharm (Pantoprazole)

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related disorders:

• Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of erosive esophagitis.
• Erosive esophagitis: accelerates healing of mucosal breaks in the esophagus.
• Zollinger‑Ellison syndrome: controls excessive gastric acid production associated with gastrin‑secreting tumors.
• Peptic ulcer disease (duodenal and gastric ulcers): supports ulcer healing and reduces recurrence risk.
• Helicobacter pylori eradication regimens: used as part of combination therapy to improve eradication rates.

• Pantoprazole selectively inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By binding covalently to the pump in its active state, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduction of gastric acidity.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects

• Headache: mild to moderate intensity.
• Diarrhea: usually transient.
• Nausea or abdominal discomfort.
• Flatulence or bloating.
• Constipation: occasional.
• Dry mouth.

Serious or Rare Side Effects

• Severe allergic reactions (anaphylaxis, angio‑edema).
• Clostridioides difficile‑associated colitis.
• Acute interstitial nephritis.
• Low magnesium levels (hypomagnesemia) with prolonged use.
• Fracture risk with long‑term high‑dose therapy.
• Liver enzyme elevations.

When prescribing Pantoprazole, consider the following precautions:

• Assess renal and hepatic function: dose adjustment may be needed in severe impairment.
• Review concomitant medications: potential for altered absorption of drugs that require acidic pH.
• Monitor long‑term users: watch for magnesium deficiency, bone health, and possible infections.
• Use during pregnancy: only if clearly needed; weigh potential benefits against risks.
• Breastfeeding: small amounts are excreted in milk; consider risk‑benefit.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may affect the pharmacokinetics of several medicines.

Major Interactions (Avoid)

• Antifungal agents (ketoconazole, itraconazole): reduced absorption and efficacy.
• HIV protease inhibitors (atazanavir, nelfinavir): markedly decreased plasma levels.
• Clopidogrel: possible reduction in antiplatelet effect.

Moderate Interactions (Monitor Closely)

• Warfarin: may increase INR; monitor coagulation parameters.
• Methotrexate: reduced renal clearance, especially at high doses.
• Digoxin: increased serum concentrations.
• Iron salts and certain vitamins (B12, folic acid): decreased absorption; consider timing separation.